Greetings from ISPOR Europe!
STRATENYM is a boutique firm comprising a global network of expert consultants, providing strategy and value in health communications for HEOR, market access, and reimbursement initiatives.
Build your brand. Reveal its value.
Why should payers reimburse your product? Why should physicians prescribe it?
- What value does your brand add to the current treatment landscape?
- What are the distinguishing features of your brand?
- Which of those do stakeholders actually care about?
Partner with STRATENYM to translate your strategy into success.
At STRATENYM, we distill product evidence into compelling value-driven content.
We have decades of experience in the pharma industry and unique expertise communicating health economics.
Recently, our consultants have helped clients with:
- Abstracts and posters/slide presentations: eg, ISPOR, ESH, ESC, ERS, CHEST, AMMI Canada
- Manuscripts published in peer-reviewed journals: eg, New England Journal of Medicine, Chest, Current Medical Research & Opinion, Journal of Managed Care and Specialty Pharmacy
- HTA dossiers: eg, NICE STA and HST submissions, Canadian submissions (CADTH CDR, pCODR, INESSS), and AMCP and BCBSA Evidence Street dossiers
- Targeted reviews on PROs, treatment landscape, and CER evidence
- Systematic Literature Reviews (SLRs) for reimbursement submissions
- BIA and CEA reports
- Value message maps, value stories, objection handlers
- Global Value Dossiers (GVDs)
- Clinical summaries
Let our industry-specific expertise drive your brand’s success in the marketplace.
If you’re attending the conference, come join the conversation on Twitter!
Here are our latest thoughts and Tweets:
What #ISPOREurope topic is still on your mind? We're thinking about how novelty is included in #HTA. In a case study analysis of 8 HTA agencies, it was revealed that novelty wasn't explicitly mentioned as a criterion and that the agencies differed in how they addressed novelty. https://t.co/QPEEFiMo5kRead More
Which #ISPOREurope sessions are you looking forward to today? We’re excited to see our #HTA poster on this afternoon in Session 4, and we can’t wait to hear from AmerisourceBergen and its presenters discussing components of the EU joint HTA regulation.Read More
Today is the day! Come join us from 15:00 - 18:00 CET in #Poster Session 4. The three co-authors will be there to answer questions & lead the discussion. #ISPOREurope #HTA #HEOR #Pharma #Research https://t.co/EGYttdmaXgRead More
Thank you #ISPOREurope for a fantastic day. We are looking forward to joining the many more insightful sessions yet to come. 4/4 #HTA #HEOR #PatientOutcomes #ISPORiansRead More
Thank you #ISPOREurope for a fantastic day. We are looking forward to joining the many more insightful sessions yet to come. #HTA #HEOR #PatientOutcomes #ISPORiansRead More
This year, #ISPOREurope will take place virtually and in Vienna, Austria. As a distributed team and #remotefirst organization, we're excited to once again be a part of the global #HEOR conversation. https://t.co/J26E0GYDc8Read More